177 related articles for article (PubMed ID: 18662913)
1. Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts.
Unal M; Yücel I
Br J Ophthalmol; 2008 Oct; 92(10):1411-4. PubMed ID: 18662913
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes.
Javadi MA; Feizi S; Karbasian A; Rastegarpour A
Br J Ophthalmol; 2010 Nov; 94(11):1464-7. PubMed ID: 20576763
[TBL] [Abstract][Full Text] [Related]
3. [Penetrating keratoplasty in high-risk children: prevention of graft rejection].
Pleskova AV; Khvatova AV
Vestn Oftalmol; 2014; 130(3):17-20. PubMed ID: 25098116
[TBL] [Abstract][Full Text] [Related]
4. Topical cyclosporine in pediatric keratoplasty.
Cosar CB; Laibson PR; Cohen EJ; Rapuano CJ
Eye Contact Lens; 2003 Apr; 29(2):103-7. PubMed ID: 12695714
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
Price MO; Price FW
Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
[TBL] [Abstract][Full Text] [Related]
6. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
Xi XH; Qin B; Jiang DY
Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
[TBL] [Abstract][Full Text] [Related]
7. A novel cyclosporine a drug-delivery system for prevention of human corneal rejection after high-risk keratoplasty: a clinical study.
Shi W; Chen M; Xie L; Liu M; Gao H; Wang T; Wu X; Zhao J
Ophthalmology; 2013 Apr; 120(4):695-702. PubMed ID: 23246118
[TBL] [Abstract][Full Text] [Related]
8. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas.
Li J; Yu L; Deng Z; Wang L; Sun L; Ma H; Chen W
Am J Ophthalmol; 2011 Nov; 152(5):762-70.e3. PubMed ID: 21803324
[TBL] [Abstract][Full Text] [Related]
9. [Interim results from the prospective "Erlanger Non-high-risk Penetrating Keratoplasty Study" in 207 patients].
Graupner M; Seitz B; Langenbucher A; Martus P; Blüthner K; Nguyen NX; Wenkel H; Küchle M
Klin Monbl Augenheilkd; 2000 Sep; 217(3):163-70. PubMed ID: 11076347
[TBL] [Abstract][Full Text] [Related]
10. [Long-term outcome of topical cyclosporine treatment following penetrating keratoplasty].
Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):306-10. PubMed ID: 10339976
[TBL] [Abstract][Full Text] [Related]
11. Long-term comparison of full-bed deep lamellar keratoplasty with penetrating keratoplasty in treating corneal leucoma caused by herpes simplex keratitis.
Wu SQ; Zhou P; Zhang B; Qiu WY; Yao YF
Am J Ophthalmol; 2012 Feb; 153(2):291-299.e2. PubMed ID: 21996306
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term corticosteroid eye drops after penetrating keratoplasty: a prospective, randomized, clinical trial.
Shimazaki J; Iseda A; Satake Y; Shimazaki-Den S
Ophthalmology; 2012 Apr; 119(4):668-73. PubMed ID: 22264885
[TBL] [Abstract][Full Text] [Related]
14. [Advantages and limits of multiple grafts (third keratoplasty) under local cyclosporin 2%].
Alalwani H; Omer Saleh B; Rocher N; Renard G; Bourges JL; Legeais JM
J Fr Ophtalmol; 2010 Dec; 33(10):710-4. PubMed ID: 21093105
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011).
Kharod-Dholakia B; Randleman JB; Bromley JG; Stulting RD
Cornea; 2015 Jun; 34(6):609-14. PubMed ID: 25811719
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty.
Inoue K; Amano S; Kimura C; Sato T; Fujita N; Kagaya F; Kaji Y; Oshika T; Tsuru T; Araie M
Jpn J Ophthalmol; 2000; 44(3):302-5. PubMed ID: 10913651
[TBL] [Abstract][Full Text] [Related]
17. Large-diameter penetrating keratoplasty: indications and outcomes.
Skeens HM; Holland EJ
Cornea; 2010 Mar; 29(3):296-301. PubMed ID: 20118782
[TBL] [Abstract][Full Text] [Related]
18. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of topical cyclosporine A on keratoplasty rejection in rats].
Zhang W; Pan Z; Zhai C
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):140-3. PubMed ID: 11864411
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus immunosuppression in high-risk corneal grafts.
Joseph A; Raj D; Shanmuganathan V; Powell RJ; Dua HS
Br J Ophthalmol; 2007 Jan; 91(1):51-5. PubMed ID: 16956911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
